Leptin regulation of bone resorption by the sympathetic nervous system and CART

Nature

Volumn 434, Issue 7032, 2005, Pages 514-520

  Elefteriou, Florent ^a   Ahn, Jong Deok ^a   Takeda, Shu ^a,b   Starbuck, Michael ^a   Yang, Xiangli ^a   Liu, Xiuyun ^a   Kondo, Hisataka ^b   Richards, William G ^c   Bannon, Tony W ^c   Noda, Masaki ^b   Clement, Karine ^d   Valsse, Christian ^e   Karsenty, Gerard ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b Tokyo Medical and Dental University ^*  (Japan)

^c AMGEN INC   (United States)

^d SORBONNE UNIVERSITÉ   (France)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE; CELLS; ENZYME KINETICS; FUNCTIONS; NEURAL NETWORKS; SIGNAL DETECTION;

BONE MASS; BONE REMODELLING; MULTIFUNCTIONAL CELLS; OSTEOBLASTS; OSTEOCLAST DIFFERENTIATION;

NEUROLOGY;

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; COCAINE AND AMPHETAMINE REGULATED TRANSCRIPT PEPTIDE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DEOXYPYRIDINOLINE; DNA; ISOPRENALINE; LEPTIN; NEOMYCIN; OSTEOCLAST DIFFERENTIATION FACTOR; PARATHYROID HORMONE; TRANSCRIPTION FACTOR; ACTIVATING TRANSCRIPTION FACTOR 4; ATF4 PROTEIN, HUMAN; BETA 2 ADRENERGIC RECEPTOR; CARRIER PROTEIN; MC4R PROTEIN, HUMAN; MELANOCORTIN 4 RECEPTOR; MEMBRANE PROTEIN; NERVE PROTEIN; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; TNFRSF11A PROTEIN, HUMAN; TNFRSF11A PROTEIN, MOUSE; TNFSF11 PROTEIN, HUMAN; TNFSF11 PROTEIN, MOUSE; TUMOR PROTEIN;

NERVOUS SYSTEM;

ADRENERGIC SYSTEM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE; CELL DIFFERENTIATION; CONTROLLED STUDY; GENOTYPE; IMMUNOCYTOCHEMISTRY; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PHOSPHORYLATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REGULATORY MECHANISM; WESTERN BLOTTING; AMINO ACID SEQUENCE; ANIMAL; BIOLOGICAL MODEL; BONE DEVELOPMENT; CELL LINE; CHEMISTRY; CHILD; DNA RESPONSIVE ELEMENT; DRUG EFFECT; GENE DELETION; GENETICS; HUMAN; MALE; METABOLISM; NASA DISCIPLINE CELL BIOLOGY; NON-NASA CENTER; PRESCHOOL CHILD; SIGNAL TRANSDUCTION;

NASA DISCIPLINE CELL BIOLOGY; NON-NASA CENTER;

ACTIVATING TRANSCRIPTION FACTOR 4; AMINO ACID SEQUENCE; ANIMALS; BONE RESORPTION; CARRIER PROTEINS; CELL LINE; CHILD; CHILD, PRESCHOOL; CYCLIC AMP-DEPENDENT PROTEIN KINASES; GENE DELETION; HUMANS; LEPTIN; MALE; MEMBRANE GLYCOPROTEINS; MICE; MODELS, NEUROLOGICAL; NEOPLASM PROTEINS; NERVE TISSUE PROTEINS; OSTEOBLASTS; OSTEOGENESIS; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTOR, MELANOCORTIN, TYPE 4; RECEPTORS, ADRENERGIC, BETA-2; RESPONSE ELEMENTS; SIGNAL TRANSDUCTION; SYMPATHETIC NERVOUS SYSTEM; TRANSCRIPTION FACTORS;

EID: 15844384047     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/nature03398     Document Type: Article

References (18)

1. Takeda, S. et al. Leptin regulates bone formation via the sympathetic nervous system. Cell 111, 305-317 (2002).
2. Yang, X. et al. ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology; implication for Coffin-Lowry Syndrome. Cell 117, 387-398 (2004).
3. Ducy, P. et al. Leptin inhibits bone formation through a hypothalamic relay: A central control of bone mass. Cell 100, 197-207 (2000).
4. Kristensen, P. et al. Hypothalamic CART is a new anorectic peptide regulated by leptin. Nature 393, 72-76 (1998).
5. Chruscinski, A. J. et al. Targeted disruption of the beta2 adrenergic receptor gene. J. Biol. Chem. 274, 16694-16700 (1999).
6. Thomas, S. A., Matsumoto, A. M. & Palmiter, R. D. Noradrenaline is essential for mouse fetal development. Nature 374, 643-646 (1995).
7. Friedman, J. M. & Halaas, J. L. Leptin and the regulation of body weight in mammals. Nature 395, 763-770 (1998).
8. Dominici, M. et al. Hematopoietic cells and osteoblasts are derived from a common marrow progenitor after bone marrow transplantation. Proc. Natl Acad. Sci. USA 101, 11761-11766 (2004).
9. Teitelbaum, S. L. & Ross, E. P. Genetic regulation of osteoclast development and function. Nature Rev. Genet. 4, 638-619 (2003).
10. Lacey, D. L. et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93, 165-176 (1998).
11. Berkowitz, L. A., Riabowol, K. T. & Gilman, M. Z. Multiple sequence elements of a single functional class are required for cyclic AMP responsiveness of the mouse c-fos promoter. Mol. Cell. Biol. 9, 4272-4281 (1989).
12. Asnicar, M. A. et al. Absence of cocaine- and amphetamine-regulated transcript results in obesity in mice fed a high caloric diet. Endocrinology 142, 4394-4400 (2001).
13. Satoh, N. et al. Sympathetic activation of leptin via the ventromedial hypothalamus: leptin-induced increase in catecholamine secretion. Diabetes 48, 1787-1793 (1999).
14. Orwoll, B., Bouxsein, M. L., Marks, D. L., Cone, R. D. & Klein, R. F. in ORS/AAOS Presentations 2003, 71st Animal Meeting of the AAOS (ORS, San Francisco, CA, 2004).
15. Rohrer, D. K., Chruscinski, A., Schauble, E. H., Bernstein, D. & Kobilka, B. K. Cardiovascular and metabolic alterations in mice lacking both beta1- and beta2-adrenergic receptors. J. Biol. Chem. 274, 16701-16708 (1999).
16. Huszar, D. et al. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88, 131-141 (1997).
17. Takahashi, N. et al. Osteoblastic cells are involved in osteoclast formation. Endocrinology 123, 2600-2602 (1988).
18. Ducy, P. & Karsenty, G. Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene. Mol. Cell. Biol. 15, 1858-1869 (1995).